Copyright Reports & Markets. All rights reserved.

Global Medications for Treating Alcohol Dependence Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Medications for Treating Alcohol Dependence by Type
    • 1.3.1 Overview: Global Medications for Treating Alcohol Dependence Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Medications for Treating Alcohol Dependence Consumption Value Market Share by Type in 2025
    • 1.3.3 Naltrexone
    • 1.3.4 Acamprosate
    • 1.3.5 Disulfiram
    • 1.3.6 Other
  • 1.4 Global Medications for Treating Alcohol Dependence Market by Application
    • 1.4.1 Overview: Global Medications for Treating Alcohol Dependence Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Rehabilitation Institutions
    • 1.4.4 Clinic
    • 1.4.5 Retail Pharmacies
  • 1.5 Global Medications for Treating Alcohol Dependence Market Size & Forecast
  • 1.6 Global Medications for Treating Alcohol Dependence Market Size and Forecast by Region
    • 1.6.1 Global Medications for Treating Alcohol Dependence Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Medications for Treating Alcohol Dependence Market Size by Region, (2021-2032)
    • 1.6.3 North America Medications for Treating Alcohol Dependence Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Medications for Treating Alcohol Dependence Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Medications for Treating Alcohol Dependence Market Size and Prospect (2021-2032)
    • 1.6.6 South America Medications for Treating Alcohol Dependence Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Medications for Treating Alcohol Dependence Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Alkermes Inc
    • 2.1.1 Alkermes Inc Details
    • 2.1.2 Alkermes Inc Major Business
    • 2.1.3 Alkermes Inc Medications for Treating Alcohol Dependence Product and Solutions
    • 2.1.4 Alkermes Inc Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Alkermes Inc Recent Developments and Future Plans
  • 2.2 Merck Group
    • 2.2.1 Merck Group Details
    • 2.2.2 Merck Group Major Business
    • 2.2.3 Merck Group Medications for Treating Alcohol Dependence Product and Solutions
    • 2.2.4 Merck Group Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck Group Recent Developments and Future Plans
  • 2.3 Lundbeck
    • 2.3.1 Lundbeck Details
    • 2.3.2 Lundbeck Major Business
    • 2.3.3 Lundbeck Medications for Treating Alcohol Dependence Product and Solutions
    • 2.3.4 Lundbeck Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Lundbeck Recent Developments and Future Plans
  • 2.4 Alvogen
    • 2.4.1 Alvogen Details
    • 2.4.2 Alvogen Major Business
    • 2.4.3 Alvogen Medications for Treating Alcohol Dependence Product and Solutions
    • 2.4.4 Alvogen Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Alvogen Recent Developments and Future Plans
  • 2.5 Mylan
    • 2.5.1 Mylan Details
    • 2.5.2 Mylan Major Business
    • 2.5.3 Mylan Medications for Treating Alcohol Dependence Product and Solutions
    • 2.5.4 Mylan Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mylan Recent Developments and Future Plans
  • 2.6 Teva
    • 2.6.1 Teva Details
    • 2.6.2 Teva Major Business
    • 2.6.3 Teva Medications for Treating Alcohol Dependence Product and Solutions
    • 2.6.4 Teva Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Teva Recent Developments and Future Plans
  • 2.7 Sun Pharmaceutical Industries
    • 2.7.1 Sun Pharmaceutical Industries Details
    • 2.7.2 Sun Pharmaceutical Industries Major Business
    • 2.7.3 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Product and Solutions
    • 2.7.4 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Sun Pharmaceutical Industries Recent Developments and Future Plans
  • 2.8 Zydus Pharmaceuticals
    • 2.8.1 Zydus Pharmaceuticals Details
    • 2.8.2 Zydus Pharmaceuticals Major Business
    • 2.8.3 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Product and Solutions
    • 2.8.4 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Zydus Pharmaceuticals Recent Developments and Future Plans
  • 2.9 Taj Pharmaceuticals
    • 2.9.1 Taj Pharmaceuticals Details
    • 2.9.2 Taj Pharmaceuticals Major Business
    • 2.9.3 Taj Pharmaceuticals Medications for Treating Alcohol Dependence Product and Solutions
    • 2.9.4 Taj Pharmaceuticals Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Taj Pharmaceuticals Recent Developments and Future Plans
  • 2.10 TAGI Pharma Inc.
    • 2.10.1 TAGI Pharma Inc. Details
    • 2.10.2 TAGI Pharma Inc. Major Business
    • 2.10.3 TAGI Pharma Inc. Medications for Treating Alcohol Dependence Product and Solutions
    • 2.10.4 TAGI Pharma Inc. Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 TAGI Pharma Inc. Recent Developments and Future Plans
  • 2.11 Beijing Wellso Pharmaceutical Co
    • 2.11.1 Beijing Wellso Pharmaceutical Co Details
    • 2.11.2 Beijing Wellso Pharmaceutical Co Major Business
    • 2.11.3 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Product and Solutions
    • 2.11.4 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Beijing Wellso Pharmaceutical Co Recent Developments and Future Plans
  • 2.12 Glenmark Pharmaceuticals
    • 2.12.1 Glenmark Pharmaceuticals Details
    • 2.12.2 Glenmark Pharmaceuticals Major Business
    • 2.12.3 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Product and Solutions
    • 2.12.4 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Glenmark Pharmaceuticals Recent Developments and Future Plans
  • 2.13 Rusan Pharma Ltd
    • 2.13.1 Rusan Pharma Ltd Details
    • 2.13.2 Rusan Pharma Ltd Major Business
    • 2.13.3 Rusan Pharma Ltd Medications for Treating Alcohol Dependence Product and Solutions
    • 2.13.4 Rusan Pharma Ltd Medications for Treating Alcohol Dependence Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Rusan Pharma Ltd Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Medications for Treating Alcohol Dependence Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Medications for Treating Alcohol Dependence by Company Revenue
    • 3.2.2 Top 3 Medications for Treating Alcohol Dependence Players Market Share in 2025
    • 3.2.3 Top 6 Medications for Treating Alcohol Dependence Players Market Share in 2025
  • 3.3 Medications for Treating Alcohol Dependence Market: Overall Company Footprint Analysis
    • 3.3.1 Medications for Treating Alcohol Dependence Market: Region Footprint
    • 3.3.2 Medications for Treating Alcohol Dependence Market: Company Product Type Footprint
    • 3.3.3 Medications for Treating Alcohol Dependence Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Medications for Treating Alcohol Dependence Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Medications for Treating Alcohol Dependence Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Medications for Treating Alcohol Dependence Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Medications for Treating Alcohol Dependence Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Medications for Treating Alcohol Dependence Consumption Value by Type (2021-2032)
  • 6.2 North America Medications for Treating Alcohol Dependence Market Size by Application (2021-2032)
  • 6.3 North America Medications for Treating Alcohol Dependence Market Size by Country
    • 6.3.1 North America Medications for Treating Alcohol Dependence Consumption Value by Country (2021-2032)
    • 6.3.2 United States Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Medications for Treating Alcohol Dependence Consumption Value by Type (2021-2032)
  • 7.2 Europe Medications for Treating Alcohol Dependence Consumption Value by Application (2021-2032)
  • 7.3 Europe Medications for Treating Alcohol Dependence Market Size by Country
    • 7.3.1 Europe Medications for Treating Alcohol Dependence Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 7.3.3 France Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Medications for Treating Alcohol Dependence Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Medications for Treating Alcohol Dependence Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Medications for Treating Alcohol Dependence Market Size by Region
    • 8.3.1 Asia-Pacific Medications for Treating Alcohol Dependence Consumption Value by Region (2021-2032)
    • 8.3.2 China Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 8.3.5 India Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Medications for Treating Alcohol Dependence Consumption Value by Type (2021-2032)
  • 9.2 South America Medications for Treating Alcohol Dependence Consumption Value by Application (2021-2032)
  • 9.3 South America Medications for Treating Alcohol Dependence Market Size by Country
    • 9.3.1 South America Medications for Treating Alcohol Dependence Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Medications for Treating Alcohol Dependence Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Medications for Treating Alcohol Dependence Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Medications for Treating Alcohol Dependence Market Size by Country
    • 10.3.1 Middle East & Africa Medications for Treating Alcohol Dependence Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Medications for Treating Alcohol Dependence Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Medications for Treating Alcohol Dependence Market Drivers
  • 11.2 Medications for Treating Alcohol Dependence Market Restraints
  • 11.3 Medications for Treating Alcohol Dependence Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Medications for Treating Alcohol Dependence Industry Chain
  • 12.2 Medications for Treating Alcohol Dependence Upstream Analysis
  • 12.3 Medications for Treating Alcohol Dependence Midstream Analysis
  • 12.4 Medications for Treating Alcohol Dependence Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Medications for Treating Alcohol Dependence market size was valued at US$ 822 million in 2025 and is forecast to a readjusted size of US$ 2115 million by 2032 with a CAGR of 14.6% during review period.
    This report is a detailed and comprehensive analysis for global Medications for Treating Alcohol Dependence market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Medications for Treating Alcohol Dependence market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Medications for Treating Alcohol Dependence market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Medications for Treating Alcohol Dependence market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Medications for Treating Alcohol Dependence market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Medications for Treating Alcohol Dependence
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Medications for Treating Alcohol Dependence market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alkermes Inc, Merck Group, Lundbeck, Alvogen, Mylan, Teva, Sun Pharmaceutical Industries, Zydus Pharmaceuticals, Taj Pharmaceuticals, TAGI Pharma Inc., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Medications for Treating Alcohol Dependence market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Naltrexone
    Acamprosate
    Disulfiram
    Other
    Market segment by Application
    Hospital
    Rehabilitation Institutions
    Clinic
    Retail Pharmacies
    Market segment by players, this report covers
    Alkermes Inc
    Merck Group
    Lundbeck
    Alvogen
    Mylan
    Teva
    Sun Pharmaceutical Industries
    Zydus Pharmaceuticals
    Taj Pharmaceuticals
    TAGI Pharma Inc.
    Beijing Wellso Pharmaceutical Co
    Glenmark Pharmaceuticals
    Rusan Pharma Ltd
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Medications for Treating Alcohol Dependence product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Medications for Treating Alcohol Dependence, with revenue, gross margin, and global market share of Medications for Treating Alcohol Dependence from 2021 to 2026.
    Chapter 3, the Medications for Treating Alcohol Dependence competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Medications for Treating Alcohol Dependence market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Medications for Treating Alcohol Dependence.
    Chapter 13, to describe Medications for Treating Alcohol Dependence research findings and conclusion.

    Buy now